{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T07:23:06Z","timestamp":1780557786498,"version":"3.54.1"},"reference-count":56,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Oradea, Romania"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Complete atrioventricular (AV) block is a severe conduction abnormality caused by intrinsic cardiac disease, ischemia, electrolyte imbalances, or drug interactions. Elderly patients on multiple medications are particularly vulnerable to polypharmacy-related interactions. This case report describes an 82-year-old female presenting to the emergency department with fatigue, syncope, and disorientation. Her medical history included atrial fibrillation, hypertension, and heart failure, with a medication regimen of digoxin 0.25 mg given daily 5 days out of 7, metoprolol 50 mg twice daily, lisinopril 10 mg daily, furosemide 40 mg daily, and spironolactone 50 mg daily. Clinical examination revealed bradycardia and a holosystolic murmur in the mitral valve area, while the electrocardiogram showed complete AV block at a ventricular rate of 35 bpm. Laboratory results indicated mild hyperkalemia (4.9 mmol\/L). Suspecting a digoxin\u2013beta-blocker interaction, antiarrhythmic therapy was discontinued. Within three days, the AV block resolved, transitioning to atrial fibrillation with a high ventricular rate. Bisoprolol was introduced for rate control, and hemodynamic stability was achieved. The patient was discharged with a revised medication regimen and showed no recurrence of AV block. This case emphasizes the importance of recognizing drug interactions as a reversible cause of AV block and using drug interaction checkers to manage polypharmacy, especially in elderly patients with multiple comorbidities. It also highlights the rare and paradoxical combination of atrial flutter and complete AV block.<\/jats:p>","DOI":"10.3390\/life15020215","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T09:16:26Z","timestamp":1738314986000},"page":"215","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Drug-Induced Complete Atrioventricular Block in an Elderly Patient: A Case Report Highlighting Digoxin-Beta Blocker Interactions and a Paradoxical State"],"prefix":"10.3390","volume":"15","author":[{"given":"Cristiana","family":"Bustea","sequence":"first","affiliation":[{"name":"Department of Preclinical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7625-8177","authenticated-orcid":false,"given":"Andrei-Flavius","family":"Radu","sequence":"additional","affiliation":[{"name":"Department of Preclinical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"},{"name":"Doctoral School of Biological and Biomedical Sciences, University of Oradea, 410087 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5071-9601","authenticated-orcid":false,"given":"Cosmin Mihai","family":"Vesa","sequence":"additional","affiliation":[{"name":"Department of Preclinical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"},{"name":"Doctoral School of Biological and Biomedical Sciences, University of Oradea, 410087 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada","family":"Radu","sequence":"additional","affiliation":[{"name":"Doctoral School of Biological and Biomedical Sciences, University of Oradea, 410087 Oradea, Romania"},{"name":"Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 410028 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teodora Maria","family":"Bodog","sequence":"additional","affiliation":[{"name":"Doctoral School of Biological and Biomedical Sciences, University of Oradea, 410087 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruxandra Florina","family":"Bodog","sequence":"additional","affiliation":[{"name":"Doctoral School of Biological and Biomedical Sciences, University of Oradea, 410087 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula Bianca","family":"Maghiar","sequence":"additional","affiliation":[{"name":"Department of Surgical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian Marius","family":"Maghiar","sequence":"additional","affiliation":[{"name":"Doctoral School of Biological and Biomedical Sciences, University of Oradea, 410087 Oradea, Romania"},{"name":"Department of Surgical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.recesp.2012.01.025","article-title":"Bradyarrhythmias and Conduction Blocks","volume":"65","author":"Vogler","year":"2012","journal-title":"Rev. Esp. Cardiol. (Engl. Ed.)"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Tagarakis, G., Gheni, A., and Hashim, H.T. (2023). Complete Heart Block (CHB). Clinical and Surgical Aspects of Congenital Heart Diseases, Springer.","DOI":"10.1007\/978-3-031-23062-2"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.02.032","article-title":"ACC\/AHA\/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC\/AHA\/NASPE 2002 Guideline","volume":"51","author":"Epstein","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_4","unstructured":"Kashou, A.H., Goyal, A., Nguyen, T., Ahmed, I., and Chhabra, L. (2024, November 24). Atrioventricular Block, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459147\/."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e003564","DOI":"10.1161\/CIRCOUTCOMES.117.003564","article-title":"Incidence and Time Course for Developing Heart Failure With High-Burden Right Ventricular Pacing","volume":"10","author":"Merchant","year":"2017","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1111\/j.1540-8159.2012.03489.x","article-title":"A Review on Advanced Atrioventricular Block in Young or Middle-Aged Adults","volume":"35","author":"Barra","year":"2012","journal-title":"Pacing Clin. Electrophysiol."},{"key":"ref_7","first-page":"e1244","article-title":"Clinical Characteristics and Outcomes of Patients with Ischemic and Non-Ischemic Complete Heart Block","volume":"9","author":"Sundhu","year":"2017","journal-title":"Cureus"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jacep.2015.08.007","article-title":"Complete Heart Block Complicating ST-Segment Elevation Myocardial Infarction","volume":"1","author":"Harikrishnan","year":"2015","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1177\/0961203319881198","article-title":"Complete Heart Block in Lupus","volume":"28","author":"Natsheh","year":"2019","journal-title":"Lupus"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1016\/j.amjcard.2018.03.350","article-title":"A Life-Threatening Condition: Hyperkalemia-Induced Complete Heart Block","volume":"121","author":"Aksu","year":"2018","journal-title":"Am. J. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e451","DOI":"10.1161\/CIRCULATIONAHA.112.101485","article-title":"Lyme Disease and the Heart","volume":"127","author":"Krause","year":"2013","journal-title":"Circulation"},{"key":"ref_12","unstructured":"Knabben, V., Chhabra, L., and Slane, M. (2024, November 24). Third-Degree Atrioventricular Block, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK545199\/."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Zhang, J., Liu, J., Ye, M., Zhang, M., Yao, F., and Cheng, Y. (2024). Incidence and Risk Factors Associated with Atrioventricular Block in the General Population: The Atherosclerosis Risk in Communities Study and Cardiovascular Health Study. BMC Cardiovasc. Disord., 24.","DOI":"10.1186\/s12872-024-04163-9"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"6276438","DOI":"10.1155\/2018\/6276438","article-title":"Alleviation of Drugs and Chemicals Toxicity: Biomedical Value of Antioxidants","volume":"2018","author":"Aleya","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Radu, A.-F., Bungau, S.G., Corb Aron, R.A., Tarce, A.G., Bodog, R., Bodog, T.M., and Radu, A. (2024). Deciphering the Intricate Interplay in the Framework of Antibiotic-Drug Interactions: A Narrative Review. Antibiotics, 13.","DOI":"10.3390\/antibiotics13100938"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1161\/CIR.0000000000000905","article-title":"Drug-Induced Arrhythmias: A Scientific Statement from the American Heart Association","volume":"142","author":"Tisdale","year":"2020","journal-title":"Circulation"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1192\/apt.bp.106.002725","article-title":"Cardiovascular Monitoring with Acetylcholinesterase Inhibitors: A Clinical Protocol","volume":"13","author":"Rowland","year":"2007","journal-title":"Adv. Psychiatr. Treat."},{"key":"ref_18","first-page":"3402","article-title":"AHMAD Prevalence of Drug to Drug Interactions in Critical Cardiac Patients","volume":"41","author":"Win","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s40545-021-00348-1","article-title":"Potential Drug\u2013Drug Interactions in Patients with Cardiovascular Diseases: Findings from a Prospective Observational Study","volume":"14","author":"Akbar","year":"2021","journal-title":"J. Pharm. Policy Pract."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s11739-024-03629-0","article-title":"Combination Therapy of Beta-Blockers and Digoxin Is Associated with Increased Risk of Major Adverse Cardiovascular Events and All-Cause Mortality in Patients with Atrial Fibrillation: A Report from the GLORIA-AF Registry","volume":"19","author":"Lam","year":"2024","journal-title":"Intern. Emerg. Med."},{"key":"ref_21","first-page":"1","article-title":"Calcium Channel Blocker and Beta Blocker Overdose, and Digoxin Toxicity Management","volume":"22","author":"Palatnick","year":"2020","journal-title":"Emerg. Med. Pract."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.amjcard.2008.09.064","article-title":"Comparison of Beta Blocker and Digoxin Alone and in Combination for Management of Patients with Atrial Fibrillation and Heart Failure","volume":"103","author":"Fauchier","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"World Medical Association Declaration of Helsinki (2014). Ethical Principles for Medical Research Involving Human Subjects. J. Am. Coll. Dent., 81, 14\u201318.","DOI":"10.1515\/jwiet-2014-0117"},{"key":"ref_24","first-page":"e382","article-title":"2018 ACC\/AHA\/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhyth","volume":"140","author":"Kusumoto","year":"2019","journal-title":"Circulation"},{"key":"ref_25","first-page":"3026","article-title":"The Management of Acute Onset Complete Heart Block and Atrial Flutter in a Patient with COVID-19","volume":"9","author":"Hussain","year":"2022","journal-title":"Eur. J. Case Reports Intern. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/01.CIR.95.3.650","article-title":"Incidence of Induced Atrial Fibrillation\/Flutter in Complete Atrioventricular Block. A Concept of \u201catrial-Malfunctioning\u201d Atrio-Hisian Block","volume":"95","author":"Yamashita","year":"1997","journal-title":"Circulation"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.hrcr.2015.06.015","article-title":"Unusual Mechanism of Complete Atrioventricular Block Following Atrial Flutter Ablation","volume":"1","author":"Georger","year":"2015","journal-title":"HeartRhythm Case Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijcard.2005.11.115","article-title":"Congenital Complete Heart Block and Maternal Connective Tissue Disease","volume":"112","author":"Jayaprasad","year":"2006","journal-title":"Int. J. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Gona, S.R., Rosenberg, J., Fyffe-Freil, R.C., Kozakiewicz, J.M., and Money, M.E. (2023). Review: Failure of Current Digoxin Monitoring for Toxicity: New Monitoring Recommendations to Maintain Therapeutic Levels for Efficacy. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1179892"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.amjmed.2024.08.018","article-title":"Expert Consensus on the Diagnosis and Management of Digoxin Toxicity","volume":"138","author":"Hack","year":"2025","journal-title":"Am. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e37034","DOI":"10.1097\/MD.0000000000037034","article-title":"A Case of Digoxin Intoxication Caused by Short-Term Massive Overdose: Case Report","volume":"103","author":"Li","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.4103\/jfmpc.jfmpc_1850_23","article-title":"Falling into Complexity: A Case of Digitalis-Induced Fall, Trauma, Symptomatic Bradycardia, and Syncope","volume":"13","author":"Ravikumar","year":"2024","journal-title":"J. Fam. Med. Prim. Care"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1136\/ejhpharm-2020-002603","article-title":"Drug-Related Bradycardia Precipitating Hospital Admission in Older Adults: An Ongoing Problem","volume":"29","author":"Griffiths","year":"2022","journal-title":"Eur. J. Hosp. Pharm. Sci. Pract."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4070\/kcj.2009.39.9.367","article-title":"Prognosis and Natural History of Drug-Related Bradycardia","volume":"39","author":"Lee","year":"2009","journal-title":"Korean Circ. J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.15420\/cfr.2015:28:2","article-title":"Beta-Blockers or Digoxin for Atrial Fibrillation and Heart Failure?","volume":"2","author":"Fauchier","year":"2016","journal-title":"Card. Fail. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"A669","DOI":"10.1016\/j.chest.2024.06.457","article-title":"Digoxin Toxicity in a Patient with Sick Sinus Syndrome: A Case Complicated by Acute Kidney Injury and Concurrent Amiodarone Use","volume":"166","author":"Nguyen","year":"2024","journal-title":"Chest"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1248\/bpb.b24-00305","article-title":"Evaluation of \u03b2-Blocker-Induced Bradyarrhythmia Using an Analysis of the Japanese Adverse Drug Event Report Database","volume":"47","author":"Motoishi","year":"2024","journal-title":"Biol. Pharm. Bull."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Gheorghe, G., Toth, P.P., Bungau, S., Behl, T., Ilie, M., Stoian, A.P., Bratu, O.G., Bacalbasa, N., Rus, M., and Diaconu, C.C. (2020). Cardiovascular Risk and Statin Therapy Considerations in Women. Diagnostics, 10.","DOI":"10.3390\/diagnostics10070483"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"D1200","DOI":"10.1093\/nar\/gkab880","article-title":"DDInter: An Online Drug-Drug Interaction Database towards Improving Clinical Decision-Making and Patient Safety","volume":"50","author":"Xiong","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s12012-018-9467-x","article-title":"Complete Atrioventricular Block in an Elderly Patient Treated with Low-Dose Lacosamide","volume":"18","author":"Lachuer","year":"2018","journal-title":"Cardiovasc. Toxicol."},{"key":"ref_41","unstructured":"Medscape Interactions Checker (2024, November 26). Drug Interactions Between Digoxin and Metoprolol. Available online: https:\/\/reference.medscape.com\/drug-interactionchecker."},{"key":"ref_42","unstructured":"Drugs.Com Interactions Checker (2024, November 26). Drug Interactions between Digoxin and Metoprolol. Available online: https:\/\/www.drugs.com\/interactions-check.php?drug_list=883-0,1615-0."},{"key":"ref_43","unstructured":"WebMD Interactions Checker (2024, November 26). Drug Interactions between Digoxin and Metoprolol. Available online: https:\/\/www.webmd.com\/interaction-checker\/default.htm."},{"key":"ref_44","unstructured":"DrugBank Interactions Checker (2024, November 26). Drug Interactions between Digoxin and Metoprolol. Available online: https:\/\/go.drugbank.com\/drug-interaction-checker#results."},{"key":"ref_45","unstructured":"DDInter Interactions Checker (2024, November 26). Drug Interactions between Digoxin and Metoprolol. Available online: https:\/\/ddinter.scbdd.com\/inter-checker\/."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1093\/eurheartj\/ehab724.3005","article-title":"Efficacy & Tolerability of Bisoprolol in Comparison to Metoprolol in Indian Patients with Stage-1 Hypertension: Multicentre, Parallel Group, Open Labelled, Randomised Noninferiority Clinical Study","volume":"42","author":"Dasbiswas","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/pds.3748","article-title":"Risk of Hyperkalemia and Combined Use of Spironolactone and Long-Term ACE Inhibitor\/Angiotensin Receptor Blocker Therapy in Heart Failure Using Real-Life Data: A Population- and Insurance-Based Cohort","volume":"24","author":"Abbas","year":"2015","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1136\/postgradmedj-2020-139701","article-title":"Diuretic-Induced Hypokalaemia: An Updated Review","volume":"98","author":"Lin","year":"2022","journal-title":"Postgrad. Med. J."},{"key":"ref_49","first-page":"1","article-title":"Hyperkalemia-Induced Complete Heart Block","volume":"1","author":"Baratloo","year":"2014","journal-title":"J. Emerg. Pract. Trauma"},{"key":"ref_50","first-page":"467","article-title":"The Effect of Hyperkalaemia on Cardiac Rhythm Devices","volume":"16","author":"Barold","year":"2014","journal-title":"EP Eur."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/MEJ.0000000000001065","article-title":"Diagnosis and Practical Management of Digoxin Toxicity: A Narrative Review and Consensus","volume":"30","author":"Andrews","year":"2023","journal-title":"Eur. J. Emerg. Med."},{"key":"ref_52","first-page":"e6056","article-title":"Digoxin Toxicity in a Patient with Pacemaker: A Case Report","volume":"11","author":"Bridwell","year":"2019","journal-title":"Cureus"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"9","DOI":"10.22270\/jddt.v12i5-S.5717","article-title":"Case Report on the Interaction between Furosemide and Digoxin That Caused Digoxin Toxicity","volume":"12","author":"Patel","year":"2022","journal-title":"J. Drug Deliv. Ther."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"39","DOI":"10.51262\/ejtox.879398","article-title":"Digoxin\u2019s Interactions with Various Drugs and A Case Report","volume":"3","author":"Yalcin","year":"2021","journal-title":"Eur. J. Toxicol."},{"key":"ref_55","first-page":"e17599","article-title":"A Case of Digoxin Toxicity Due to Acute Renal Failure","volume":"13","author":"Duke","year":"2021","journal-title":"Cureus"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijcard.2016.06.202","article-title":"Addition of Beta-Blockers to Digoxin Is Associated with Improved 1- and 10-Year Survival of Patients Hospitalized Due to Decompensated Heart Failure","volume":"221","author":"Katz","year":"2016","journal-title":"Int. J. Cardiol."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/2\/215\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:24:59Z","timestamp":1760027099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/2\/215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":56,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["life15020215"],"URL":"https:\/\/doi.org\/10.3390\/life15020215","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,31]]}}}